Growth Healthtech Lauxera is a growth-focused Healthtech investor with leadership in Europe and the US, presenting opportunities to engage portfolio companies or explore co-investment/financing discussions for growth-stage medical devices, digital health, and healthcare data ventures.

Strategic Investments Recent and planned investments in genomics, neurovascular devices, and healthcare software indicate a hunger for enabling technologies and data connectivity; sales conversations can target portfolio-firm needs for regulatory-compliant IT, data analytics, and cloud-enabled solutions.

Acquisitions & Platforms Active M&A activity including acquisitions of Matrix Requirements and Galen Data suggests potential demand for medical device development enablement tools, QMS/ALM software, cloud connectivity, and interoperability solutions to accelerate integration post-transaction.

Global Reach With offices in Paris and San Francisco and a multi-market focus including Europe and the US, there are cross-border sales opportunities for platforms that support international regulatory, distribution, and compliance needs.

Talent & Scale Significant headcount growth (noted 400 new jobs since 2021) and a growing portfolio imply a need for scalable infrastructure, partner networks, and BD/ops support to sustain portfolio expansion and market entry strategies.